From Banding to BAM Files: Genomics Informs Diagnosis and Precision Medicine for Brain Tumors.
Brain tumors
Central nervous system (CNS)
Cytogenetics
Epigenomics
Genomics
Next-generation sequencing
Journal
Surgical pathology clinics
ISSN: 1875-9157
Titre abrégé: Surg Pathol Clin
Pays: United States
ID NLM: 101491209
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
12
5
2020
pubmed:
12
5
2020
medline:
20
3
2021
Statut:
ppublish
Résumé
Tumors of the central nervous system (CNS) have been historically classified according to their morphologic and immunohistochemical features. In 2016, updates to the classification of tumors of the CNS by the World Health Organization revolutionized this paradigm. For the first time, genomic findings, whether whole-arm chromosomal aberrations or single nucleotide variants, represent a necessary and critical component of diagnosis, contributing or superseding histologic findings. These updates stem from decades of technical innovation and genomic discovery. During this time, there has been a dramatic expansion and evolution in clinical genomic assays for these tumors, informing diagnosis and guiding therapeutic management.
Identifiants
pubmed: 32389271
pii: S1875-9181(20)30013-1
doi: 10.1016/j.path.2020.02.007
pii:
doi:
Substances chimiques
Genetic Markers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-347Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.